Monopar Therapeutics Inc. · NASDAQ:MNPR

Robinson Chandler had 597 Monopar Therapeutics Inc. shares withheld for tax (Form 4)

Traded Oct 20, 2026 · Filed Oct 20, 2026

On Oct 20, 2026, Robinson Chandler (Director, Chief Executive Officer) had 597 Monopar Therapeutics Inc. shares withheld for tax at US$92.59 for US$55,276, leaving 104,127 shares. Filed Oct 20, 2026 (Form 4).

Withheld for tax
597 shares
Price
US$92.59
Value
US$55,276
Holding after
104,127 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 20, 2026Common StockShares withheld for tax597US$92.59104,127Direct

Source

Download original · View original at SEC

Related